EDNRA and type 2 diabetes mellitus: It should also be noted, though, that other studies were unable to demonstrate increased forearm flow with ETA/ETA/B receptor antagonism in volunteers with excessive weight and type 2 diabetes (Cardillo et al., 2004; Schreuder et al., 2014; Table 2).